Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomas.

Mitsuko FuruyaYasuhiro IribeYoji NagashimaNaotomo KambeChisato OheHidefumi KinoshitaChika SatoTakeshi KishidaYoichiro OkuboKazuyuki NumakuraHiroshi NanjoNoboru NakaigawaKazuhide MakiyamaHisashi HasumiHiromichi IwashitaJunichi OhtaHiroshi KitamuraTakahiko NakajimaTakahiro YoshidaMasahiro NakagawaReiko TanakaMasahiro Yao

Published in: Journal of clinical pathology (2020)

HLRCC-RCCs appear to have unique molecular profiles, including PD-L1 expression. One patient had complete response to immunotherapy, which may be an option for HLRCC-RCC.

Keyphrases

single cell
cell therapy
case report
stem cells
high grade
bone marrow